QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment 期刊论文 Recent Patents on Anti-Cancer Drug Discovery, 2016, 卷号: 11, 期号: 2, 页码: 184-196 作者:  Huang, Li;  He, Rongzhang;  Luo, Weihao;  Zhu, Yuan-Shan;  Li, Jia 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/03 AKR1B10  ARL-1  Aldo-keto reductase  cancer  chemoresistance  inhibitors   Human 3 alpha-hydroxysteroid dehydrogenase type 3: structural clues of 5 alpha-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth 期刊论文 BIOCHEMICAL JOURNAL, 2016, 卷号: 473 作者:  Zhang, Bo;  Hu, Xiao-Jian;  Wang, Xiao-Qiang;  Theriault, Jean-Francois;  Zhu, Dao-Wei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13 aldo-keto reductase 1C2 (AKR1C2)  cancer cell growth  crystal structure  5 alpha-dihydrotestosterone (5 alpha-DHT)  3 alpha-hydroxysteroid dehydrogenase type 3 (3 alpha-HSD3)   The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate-induced esophageal squamous cell carcinoma cell death 期刊论文 2016, 卷号: 7, 期号: 16, 页码: 21542-21555 作者:  Li, Wei;  Hou, Guixue;  Zhou, Dianrong;  Lou, Xiaomin;  Xu, Yang 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04 Aldo-keto reductase 1C1/C2  Ethyl-3  4-dihydroxybenzoate  MRM  ESCC   Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker 期刊论文 Cancer biomarkers : section A of Disease markers, 2016, 卷号: 16, 期号: 1, 页码: 127-135 作者:  He, Ying-Chun;  Shen, Yi;  Cao, Yu;  Tang, Fang-Qing;  Tian, Dao-Fa 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/27 Aldo-keto reductase 1B10  nasopharyngeal carcinoma  tumor marker,squamous cell carcinoma  nasopharyngeal lesions   Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment 期刊论文 Recent Patents on Anti-Cancer Drug Discovery, 2016, 卷号: 11, 期号: 2, 页码: 184-196 作者:  Huang, Li;  He, Rongzhang;  Luo, Weihao;  Zhu, Yuan-Shan;  Li, Jia 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/27 AKR1B10  ARL-1  Aldo-keto reductase  cancer  chemoresistance  inhibitors